Kee Kiat Yeo

957 total citations
36 papers, 325 citations indexed

About

Kee Kiat Yeo is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, Kee Kiat Yeo has authored 36 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 22 papers in Neurology and 11 papers in Molecular Biology. Recurrent topics in Kee Kiat Yeo's work include Glioma Diagnosis and Treatment (26 papers), Neuroblastoma Research and Treatments (19 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Kee Kiat Yeo is often cited by papers focused on Glioma Diagnosis and Treatment (26 papers), Neuroblastoma Research and Treatments (19 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Kee Kiat Yeo collaborates with scholars based in United States, Australia and Canada. Kee Kiat Yeo's co-authors include Susan Chi, Jessica Clymer, Christine Chordas, Mary Ann Zimmerman, Sanda Alexandrescu, Tabitha Cooney, Olivia Campagne, Jason Fangusaro, Clinton F. Stewart and Chantel Cacciotti and has published in prestigious journals such as Journal of Neuropathology & Experimental Neurology, Clinical Pharmacokinetics and Modern Pathology.

In The Last Decade

Kee Kiat Yeo

32 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kee Kiat Yeo United States 10 193 156 90 60 53 36 325
Tabitha Cooney United States 10 211 1.1× 115 0.7× 82 0.9× 48 0.8× 43 0.8× 25 314
Mariko DeWire United States 14 266 1.4× 125 0.8× 194 2.2× 60 1.0× 90 1.7× 23 416
Yukitomo Ishi Japan 11 129 0.7× 85 0.5× 93 1.0× 28 0.5× 52 1.0× 55 316
Wafik Zaky United States 12 271 1.4× 110 0.7× 200 2.2× 59 1.0× 92 1.7× 66 461
Olga Zheludkova Russia 7 201 1.0× 113 0.7× 139 1.5× 21 0.3× 49 0.9× 38 307
Alessandro Sandri Italy 11 206 1.1× 117 0.8× 89 1.0× 46 0.8× 70 1.3× 19 329
Brian Rood United States 5 284 1.5× 253 1.6× 116 1.3× 49 0.8× 73 1.4× 6 385
Dali Sui China 10 184 1.0× 110 0.7× 55 0.6× 46 0.8× 68 1.3× 17 367
Jennifer Elster United States 8 133 0.7× 103 0.7× 150 1.7× 60 1.0× 51 1.0× 26 325
Julie Fleitz United States 10 143 0.7× 85 0.5× 131 1.5× 53 0.9× 58 1.1× 11 320

Countries citing papers authored by Kee Kiat Yeo

Since Specialization
Citations

This map shows the geographic impact of Kee Kiat Yeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kee Kiat Yeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kee Kiat Yeo more than expected).

Fields of papers citing papers by Kee Kiat Yeo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kee Kiat Yeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kee Kiat Yeo. The network helps show where Kee Kiat Yeo may publish in the future.

Co-authorship network of co-authors of Kee Kiat Yeo

This figure shows the co-authorship network connecting the top 25 collaborators of Kee Kiat Yeo. A scholar is included among the top collaborators of Kee Kiat Yeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kee Kiat Yeo. Kee Kiat Yeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Kevin X., Susan Chi, Karen Wright, et al.. (2025). Treatment Approach for Metastatic Intracranial Germinoma: A Multi‐Institutional Experience. Pediatric Blood & Cancer. 72(5). e31628–e31628.
2.
Yeo, Kee Kiat, Joanna J. Gell, Girish Dhall, & Ching C. Lau. (2025). Intracranial germ cell tumors: advancement in genomic diagnostics and the need for novel therapeutics. Frontiers in Oncology. 15. 1513258–1513258.
3.
Gikandi, Ajami, Susan Chi, Kee Kiat Yeo, et al.. (2024). Off‐label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer center. Cancer Medicine. 13(8). e7154–e7154. 3 indexed citations
4.
Jones, Jacquelyn, Susan Chi, Lissa Baird, et al.. (2024). METB-07. FREQUENCY AND OUTCOMES OF CDKN2A/B LOSS IN PEDIATRIC GLIOMA. Neuro-Oncology. 26(Supplement_4). 0–0.
5.
Yeo, Kee Kiat, et al.. (2024). Pediatric-type low-grade gliomas in adolescents and young adults—challenges and emerging paradigms. Child s Nervous System. 40(10). 3329–3339. 4 indexed citations
6.
Woods, Jared K., Hart G.W. Lidov, Keith L. Ligon, et al.. (2022). PD-L1 and PD-1 expression in pediatric central nervous system germ cell tumors. Modern Pathology. 35(12). 1770–1774. 7 indexed citations
7.
Lamba, Nayan, Andrew Groves, Matthew Torre, Kee Kiat Yeo, & J. Bryan Iorgulescu. (2022). The epidemiology of primary and metastatic brain tumors in infancy through childhood. Journal of Neuro-Oncology. 156(2). 419–429. 17 indexed citations
8.
Liu, Kevin X., Chantel Cacciotti, Ayal A. Aizer, et al.. (2022). DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis. Journal of Neuro-Oncology. 157(3). 499–510. 2 indexed citations
9.
Vogelzang, Jayne, et al.. (2022). Clinical Trial Enrollment Among Adolescent and Young Adults with Primary Central Nervous System Tumors Treated at the Dana-Farber Cancer Institute. Journal of Adolescent and Young Adult Oncology. 11(6). 543–549. 2 indexed citations
10.
11.
Meredith, David M., Hart G.W. Lidov, Keith L. Ligon, et al.. (2022). 104. H3K27-altered diffuse midline gliomas with secondary driver molecular alterations. Cancer Genetics. 268-269. 33–33. 1 indexed citations
12.
Ahrendsen, Jared T., Matthew Torre, David M. Meredith, et al.. (2021). IDH-mutant gliomas with additional class-defining molecular events. Modern Pathology. 34(7). 1236–1244. 17 indexed citations
13.
Yeo, Kee Kiat, et al.. (2021). Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance. Cancer Immunology Immunotherapy. 71(1). 153–164. 20 indexed citations
14.
Cacciotti, Chantel, Sanda Alexandrescu, Mary Ann Zimmerman, et al.. (2020). Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience. Journal of Neuro-Oncology. 149(1). 113–122. 53 indexed citations
15.
Campagne, Olivia, Kee Kiat Yeo, Jason Fangusaro, & Clinton F. Stewart. (2020). Clinical Pharmacokinetics and Pharmacodynamics of Selumetinib. Clinical Pharmacokinetics. 60(3). 283–303. 29 indexed citations
16.
Manoharan, Neevika, Christine Chordas, Mary Ann Zimmerman, et al.. (2020). Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma. Journal of Neuro-Oncology. 149(2). 253–262. 45 indexed citations
17.
Yeo, Kee Kiat, Ashley Margol, Rebekah Kennedy, et al.. (2019). Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens. Journal of Neuro-Oncology. 145(2). 375–383. 9 indexed citations
18.
Margol, Ashley, Kee Kiat Yeo, Caihong Xia, et al.. (2018). A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children’s Oncology Group. Journal of Neuro-Oncology. 140(3). 575–582. 9 indexed citations
19.
Robison, Nathan, Kee Kiat Yeo, Jemily Malvar, et al.. (2018). Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors. Journal of Neuro-Oncology. 138(1). 199–207. 11 indexed citations
20.
Yeo, Kee Kiat, Paul S. Gaynon, Cecilia Fu, Alan S. Wayne, & Weili Sun. (2016). Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase Intolerance. Journal of Pediatric Hematology/Oncology. 38(5). 345–349. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tabitha Cooney Breakdown of academic impact, for papers by Mariko DeWire Breakdown of academic impact, for papers by Yukitomo Ishi Breakdown of academic impact, for papers by Wafik Zaky Breakdown of academic impact, for papers by Olga Zheludkova Breakdown of academic impact, for papers by Alessandro Sandri Breakdown of academic impact, for papers by Brian Rood Breakdown of academic impact, for papers by Dali Sui Breakdown of academic impact, for papers by Jennifer Elster Breakdown of academic impact, for papers by Julie Fleitz
Rankless by CCL
2026